ARK Investment Management LLC
正式名称: ARK INVESTMENT MANAGEMENT LLC
フルコンタクト詳細
ARK Investment Management LLC
3 E. 28TH STREET, FLOOR 7, NEW YORK, NY
212-426-7040
646-668-4134
他の情報
ARK Investment Management LLCは、22名の従業員を擁するデラウェア州に拠点を置く有限責任会社であり、そのうち13名が顧問的役割を担っています。現在8つのクライアントにサービスを提供しており、同社はSECの承認を受けています。登録日は2014年1月21日に遡ります。
Attention Required! | Cloudflare
Please enable cookies. Sorry, you have been blocked You are unable to access ark-invest.com Why have I been blocked? This website is using a security service to protect itself from online attacks. The action you just performed triggered the security solution. There are several actions that could tri…
Attention Required! | Cloudflare
Please enable cookies. Sorry, you have been blocked You are unable to access ark-funds.com Why have I been blocked? This website is using a security service to protect itself from online attacks. The action you just performed triggered the security solution. There are several actions that could trig…
直接の所有者
-
ARK INVESTMENT MANAGEMENT LP
MANAGING MEMEBER 所有する 75%以上
-
BRETT MCKENZIE WINTON
DIRECTOR OF RESEARCH 所有する 5%未満
-
CATHERINE DUDDY WOOD
CHIEF EXECUTIVE OFFICER 所有する 5%未満
-
JAMES ARTHUR CHAVIS
CHIEF FINANCIAL OFFICER; CHIEF ADMINISTRATIVE OFFICER 所有する 5%未満
-
KELLEN CARTER
CHIEF COMPLIANCE OFFICER; CORPORATE COUNSEL 所有する 5%未満
-
THOMAS GREGORY STAUDT
CHIEF OPERATING OFFICER 所有する 5%未満
間接所有者
-
ARK INVESTMENT MANAGEMENT GP LLC
GENERAL PARTNER
-
CATHERINE DUDDY WOOD
MEMBER 所有する 50%以上75%未満
-
CATHERINE DUDDY WOOD
PARTNER 所有する 50%以上75%未満
近くにある会社
ニュース
- Exploring the Winds of Change: ARK Investment Management's Strategic Moves in Q4 2023 vs. Q1 2024
- ARK Investment Management LLC Q3 2023 vs. Q4 2023 13F Holdings Comparison
- ARK Investment Management LLC Q2 2023 vs. Q3 2023: A Comparative Analysis of 13F Holdings
- ARK Investment's Q4 2022 vs. Q1 2023: A Closer Look at their 13F Holdings Changes
トップホールディングス
- LENDINGCLUB CORP $338,818k
- Stratasys Ltd $226,500k
- Invitae Corp $221,444k
- Illumina Inc $197,892k
- Square Inc $181,807k
- NVIDIA Corp $175,960k
- Intellia Therapeutics Inc $134,941k
- CRISPR Therapeutics AG $128,317k
- Editas Medicine Inc $119,943k
- NanoString Technologies Inc $107,017k